Health Report - Separate stories podcast
Alzheimer's disease drug approved in the US despite concerns of clinicians
The US Food and Drug Administration has approved the first drug for Alzheimer's disease in nearly two decades. But not everyone is welcoming the decision. Here in Australia, authorities are considering whether to also give Aducanumab the green light.